Prostate Cancer UK Professionals
@prostateukprofs.bsky.social
Here we share news and views from @ProstateCancerUK for our growing professional community who have an interest in prostate disease 🧑🔬⤵️
Could androgen-regulated amyloid precursor protein processing drive #ProstateCancer development?
A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol.
Grab a ☕ and read: doi.org/10.3390/cimb...
A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol.
Grab a ☕ and read: doi.org/10.3390/cimb...
January 20, 2026 at 5:00 PM
Could androgen-regulated amyloid precursor protein processing drive #ProstateCancer development?
A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol.
Grab a ☕ and read: doi.org/10.3390/cimb...
A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol.
Grab a ☕ and read: doi.org/10.3390/cimb...
🗓️ Just 3 months to go until From Ideas to Innovation!
🚄 Book your travel now - tickets are cheaper & more options.
💸 Travel may be covered by your Prostate Cancer UK grant.
🎟️ Travel bursaries available - first come, first served.
More info 👇
prostatecanceruk.org/research/for...
🚄 Book your travel now - tickets are cheaper & more options.
💸 Travel may be covered by your Prostate Cancer UK grant.
🎟️ Travel bursaries available - first come, first served.
More info 👇
prostatecanceruk.org/research/for...
January 20, 2026 at 11:36 AM
🗓️ Just 3 months to go until From Ideas to Innovation!
🚄 Book your travel now - tickets are cheaper & more options.
💸 Travel may be covered by your Prostate Cancer UK grant.
🎟️ Travel bursaries available - first come, first served.
More info 👇
prostatecanceruk.org/research/for...
🚄 Book your travel now - tickets are cheaper & more options.
💸 Travel may be covered by your Prostate Cancer UK grant.
🎟️ Travel bursaries available - first come, first served.
More info 👇
prostatecanceruk.org/research/for...
⏰ Time's ticking ⏰
Enhance prostate cancer care and support with our dynamic Improvement Programmes team.
🚀 Final call to be a part of our Clinical Champions Cohort 5
🌟 Apply now:
Enhance prostate cancer care and support with our dynamic Improvement Programmes team.
🚀 Final call to be a part of our Clinical Champions Cohort 5
🌟 Apply now:
Clinical Champions Programme
Our 18-month long programme aims to identify future clinical leaders and provide them with the knowledge and skills to deliver improvements to prostate cancer care.
bit.ly
January 19, 2026 at 3:04 PM
⏰ Time's ticking ⏰
Enhance prostate cancer care and support with our dynamic Improvement Programmes team.
🚀 Final call to be a part of our Clinical Champions Cohort 5
🌟 Apply now:
Enhance prostate cancer care and support with our dynamic Improvement Programmes team.
🚀 Final call to be a part of our Clinical Champions Cohort 5
🌟 Apply now:
⏰ 1 month to go: CRSG proposal deadline
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
🗓 Deadline: 4pm, Fri 13 Feb
⤵️Use our form & submit your proposal below.
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
🗓 Deadline: 4pm, Fri 13 Feb
⤵️Use our form & submit your proposal below.
⏰Reminder: CRSG proposal deadline approaching
💡Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb
🔗https://buff.ly/W0foIBz
💡Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb
🔗https://buff.ly/W0foIBz
January 19, 2026 at 9:59 AM
⏰ 1 month to go: CRSG proposal deadline
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
🗓 Deadline: 4pm, Fri 13 Feb
⤵️Use our form & submit your proposal below.
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
🗓 Deadline: 4pm, Fri 13 Feb
⤵️Use our form & submit your proposal below.
🎉 BREAKING NEWS
Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland.
Stay tuned — we’ll share more on what this means for you and your patients next week.
Read more: buff.ly/jRDKPrv
Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland.
Stay tuned — we’ll share more on what this means for you and your patients next week.
Read more: buff.ly/jRDKPrv
January 16, 2026 at 6:05 PM
🎉 BREAKING NEWS
Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland.
Stay tuned — we’ll share more on what this means for you and your patients next week.
Read more: buff.ly/jRDKPrv
Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland.
Stay tuned — we’ll share more on what this means for you and your patients next week.
Read more: buff.ly/jRDKPrv
Could targeted alpha therapy be an effective treatment for advanced #ProstateCancer?
An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports.
Grab a ☕ & read: doi.org/10.1038/s415...
An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports.
Grab a ☕ & read: doi.org/10.1038/s415...
![Scientific Paper Published in Scientific Reports, titled: Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb- AB001. Written by Stenberg et al.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:dewxxsnm5un65f4aivqn4aph/bafkreianzqlufwm42564gyrxb2sqyum6z2lrd7hvi36pjc6mb6ut5zinxu@jpeg)
January 13, 2026 at 5:00 PM
Could targeted alpha therapy be an effective treatment for advanced #ProstateCancer?
An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports.
Grab a ☕ & read: doi.org/10.1038/s415...
An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports.
Grab a ☕ & read: doi.org/10.1038/s415...
Take on our step challenge, March the Month, this March. Walk 11,000 steps a day throughout March for the over 11,000 men who die of #ProstateCancer every year.
Sign up now 👉 bit.ly/44HPo01
Sign up now 👉 bit.ly/44HPo01
January 9, 2026 at 4:45 PM
Take on our step challenge, March the Month, this March. Walk 11,000 steps a day throughout March for the over 11,000 men who die of #ProstateCancer every year.
Sign up now 👉 bit.ly/44HPo01
Sign up now 👉 bit.ly/44HPo01
The UK NSC is currently running a public consultation on its draft recommendation for prostate cancer screening.
We are encouraging you to review the proposal and submit your views to help shape the final recommendation.
More details here ➡️
We are encouraging you to review the proposal and submit your views to help shape the final recommendation.
More details here ➡️
UK NSC opens consultation on draft prostate cancer screening recommendation
The UK NSC has opened a public consultation on the evidence relating to screening for prostate cancer.
nationalscreening.blog.gov.uk
January 8, 2026 at 5:01 PM
The UK NSC is currently running a public consultation on its draft recommendation for prostate cancer screening.
We are encouraging you to review the proposal and submit your views to help shape the final recommendation.
More details here ➡️
We are encouraging you to review the proposal and submit your views to help shape the final recommendation.
More details here ➡️
⏰Reminder: CRSG proposal deadline approaching
💡Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb
🔗https://buff.ly/W0foIBz
💡Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb
🔗https://buff.ly/W0foIBz
January 8, 2026 at 10:21 AM
⏰Reminder: CRSG proposal deadline approaching
💡Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb
🔗https://buff.ly/W0foIBz
💡Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form & submit your proposal.
Deadline: 4pm, Fri 13 Feb
🔗https://buff.ly/W0foIBz
How has #ProstateCancer treatment evolved over the last five years?
Prostate Cancer UK Scientific Advisory Board member Dr Jochen Walz @paoli-calmettes.bsky.social and @alison-tree.bsky.social review prostate cancer treatment progress in @thelancet.com.
Grab a ☕ and read: doi.org/10.1016/S014...
Prostate Cancer UK Scientific Advisory Board member Dr Jochen Walz @paoli-calmettes.bsky.social and @alison-tree.bsky.social review prostate cancer treatment progress in @thelancet.com.
Grab a ☕ and read: doi.org/10.1016/S014...
January 6, 2026 at 5:13 PM
How has #ProstateCancer treatment evolved over the last five years?
Prostate Cancer UK Scientific Advisory Board member Dr Jochen Walz @paoli-calmettes.bsky.social and @alison-tree.bsky.social review prostate cancer treatment progress in @thelancet.com.
Grab a ☕ and read: doi.org/10.1016/S014...
Prostate Cancer UK Scientific Advisory Board member Dr Jochen Walz @paoli-calmettes.bsky.social and @alison-tree.bsky.social review prostate cancer treatment progress in @thelancet.com.
Grab a ☕ and read: doi.org/10.1016/S014...
🗓️One week today!
🙌Join Prof Emma Hall & Claire Snowdon from the @icr-ctsu.bsky.social to learn how Clinical Trials Units can elevate your research, or your career!
⤵️Register below
🙌Join Prof Emma Hall & Claire Snowdon from the @icr-ctsu.bsky.social to learn how Clinical Trials Units can elevate your research, or your career!
⤵️Register below
📢Careers in Research Webinar📢
🤔Got a great idea, but not sure how to turn it into a clinical trial?
📉Curious about careers in trials – stats, methods, data?
Register to explore how partnering with a CTSU can support researchers at every stage 👇
events.teams.microsoft.com/event/2b9a0b...
🤔Got a great idea, but not sure how to turn it into a clinical trial?
📉Curious about careers in trials – stats, methods, data?
Register to explore how partnering with a CTSU can support researchers at every stage 👇
events.teams.microsoft.com/event/2b9a0b...
January 6, 2026 at 9:14 AM
🗓️One week today!
🙌Join Prof Emma Hall & Claire Snowdon from the @icr-ctsu.bsky.social to learn how Clinical Trials Units can elevate your research, or your career!
⤵️Register below
🙌Join Prof Emma Hall & Claire Snowdon from the @icr-ctsu.bsky.social to learn how Clinical Trials Units can elevate your research, or your career!
⤵️Register below
Thank you Adam - we're very grateful for your support this month, and for all you do year round to drive progress for men through research - always going the extra mile 🏃♂️🙏
Running 5km every day for @ProstateUK to mainly raise awareness and raise a little bit of cash if I can. Day 1-4 done. runthemonthme.prostatecanceruk.org/fundraising/...
January 6, 2026 at 8:40 AM
Thank you Adam - we're very grateful for your support this month, and for all you do year round to drive progress for men through research - always going the extra mile 🏃♂️🙏
🌟 Ready to lead the change in transforming prostate cancer care?
🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme!
🌐✨ Apply now
🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme!
🌐✨ Apply now
Clinical Champions Programme
Our 18-month long programme aims to identify future clinical leaders and provide them with the knowledge and skills to deliver improvements to prostate cancer care.
bit.ly
December 22, 2025 at 11:01 AM
🌟 Ready to lead the change in transforming prostate cancer care?
🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme!
🌐✨ Apply now
🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme!
🌐✨ Apply now
In light of the growing body of evidence around screening the APPG on #ProstateCancer we were delighted to hear from experts from within the European Praise-U consortium earlier this year about the approaches and methods being undertaken in other countries.
Read the report here: buff.ly/uqqAMNU
Read the report here: buff.ly/uqqAMNU
December 19, 2025 at 3:00 PM
In light of the growing body of evidence around screening the APPG on #ProstateCancer we were delighted to hear from experts from within the European Praise-U consortium earlier this year about the approaches and methods being undertaken in other countries.
Read the report here: buff.ly/uqqAMNU
Read the report here: buff.ly/uqqAMNU
The December edition of Research News is here! Find out about:
🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.
📚 Read it here: buff.ly/kXTXjdx
🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.
📚 Read it here: buff.ly/kXTXjdx
December 19, 2025 at 10:30 AM
The December edition of Research News is here! Find out about:
🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.
📚 Read it here: buff.ly/kXTXjdx
🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.
📚 Read it here: buff.ly/kXTXjdx
Reposted by Prostate Cancer UK Professionals
Excited to share our new study from @asharpmedonc.bsky.social lab at @icr.ac.uk 🔬✨
We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer.
So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social
🔗 bit.ly/4oHSvNx
We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer.
So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social
🔗 bit.ly/4oHSvNx
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer
Targeting anti-apoptotic BCL2 family proteins is an attractive therapeutic strategy
to drive prostate cancer (PCa) cell death. Here, we show that MCL1 is highly expressed
in castration-resistant PCa (...
www.cell.com
November 14, 2025 at 8:43 PM
Excited to share our new study from @asharpmedonc.bsky.social lab at @icr.ac.uk 🔬✨
We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer.
So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social
🔗 bit.ly/4oHSvNx
We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer.
So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social
🔗 bit.ly/4oHSvNx
Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer?
Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence.
Grab a ☕ & read: doi.org/10.1016/j.is...
Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence.
Grab a ☕ & read: doi.org/10.1016/j.is...
December 16, 2025 at 5:45 PM
Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer?
Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence.
Grab a ☕ & read: doi.org/10.1016/j.is...
Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence.
Grab a ☕ & read: doi.org/10.1016/j.is...
Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment.
Hear about current approaches, practical considerations developments within this area.
📅 Jan 28
⏰ 3:00–4:30 CEST
📍 Zoom
Register: bit.ly/492iMjT
Hear about current approaches, practical considerations developments within this area.
📅 Jan 28
⏰ 3:00–4:30 CEST
📍 Zoom
Register: bit.ly/492iMjT
December 15, 2025 at 3:21 PM
Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment.
Hear about current approaches, practical considerations developments within this area.
📅 Jan 28
⏰ 3:00–4:30 CEST
📍 Zoom
Register: bit.ly/492iMjT
Hear about current approaches, practical considerations developments within this area.
📅 Jan 28
⏰ 3:00–4:30 CEST
📍 Zoom
Register: bit.ly/492iMjT
Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.
🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
December 14, 2025 at 7:11 PM
Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.
🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
🖥️ Don't miss the next webinar from the European Prostate Cancer Alliance on 'Tumour heterogeneity and molecular imaging', featuring Prostate Cancer UK funded researchers Professor Hing Leung and Professor Craig Robson.
📆 15th December
⏰ 15:00 - 17:15
🔗 t.co/ejVkwgiij9
📆 15th December
⏰ 15:00 - 17:15
🔗 t.co/ejVkwgiij9
December 11, 2025 at 4:30 PM
🖥️ Don't miss the next webinar from the European Prostate Cancer Alliance on 'Tumour heterogeneity and molecular imaging', featuring Prostate Cancer UK funded researchers Professor Hing Leung and Professor Craig Robson.
📆 15th December
⏰ 15:00 - 17:15
🔗 t.co/ejVkwgiij9
📆 15th December
⏰ 15:00 - 17:15
🔗 t.co/ejVkwgiij9
Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments.
In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.
📙 Read more: prostatecanceruk.org/research/res...
In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.
📙 Read more: prostatecanceruk.org/research/res...
December 10, 2025 at 5:30 PM
Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments.
In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.
📙 Read more: prostatecanceruk.org/research/res...
In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.
📙 Read more: prostatecanceruk.org/research/res...
Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer?
A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.
Grab a ☕ and read: doi.org/10.1038/s414...
A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.
Grab a ☕ and read: doi.org/10.1038/s414...
December 9, 2025 at 5:01 PM
Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer?
A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.
Grab a ☕ and read: doi.org/10.1038/s414...
A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.
Grab a ☕ and read: doi.org/10.1038/s414...
If you’re a Black healthcare professional, we want to help you drive change in prostate cancer care.
Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact.
Apply now 👉
Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact.
Apply now 👉
Clinical Champions Programme
Our 18-month long programme aims to identify future clinical leaders and provide them with the knowledge and skills to deliver improvements to prostate cancer care.
bit.ly
December 9, 2025 at 10:30 AM
If you’re a Black healthcare professional, we want to help you drive change in prostate cancer care.
Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact.
Apply now 👉
Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact.
Apply now 👉
🗣️ YOUR FEEDBACK MATTERS
Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.
Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.
Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
December 6, 2025 at 1:24 PM
🗣️ YOUR FEEDBACK MATTERS
Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.
Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.
Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Screening takes time but early diagnosis can’t wait.
Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.
Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b
Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.
Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b
December 5, 2025 at 4:15 PM
Screening takes time but early diagnosis can’t wait.
Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.
Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b
Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.
Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b